IPHA vs ENLV
Comparison between Innate Pharma (IPHA, Company) and Enlivex Therapeutics Ltd (ENLV, Company).
Both IPHA and ENLV are from the Healthcare sector.
5-Year PerformanceIPHA has outperformed ENLV, delivering a return of -15.7% compared to -41.2%
IPHA vs ENLV - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
IPHA vs ENLV - Historical Returns
Returns include dividend reinvestment.
IPHA vs ENLV - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | IPHA | ENLV |
|---|---|---|
| 2026 | -3.30% | -11.23% |
| 2025 | -6.42% | -43.29% |
| 2024 | -32.35% | -64.55% |
| 2023 | -17.65% | -34.15% |
| 2022 | -22.29% | -40.88% |
| 2021 | +5.80% | -35.23% |
| 2020 | -43.97% | -2.77% |
| 2019 | +6.45% | +23.37% |
| 2018 | N/A | -65.14% |
| 2017 | N/A | -58.06% |
| 2016 | N/A | -72.63% |
| 2015 | N/A | -41.41% |
| 2014 | N/A | -23.93% |
IPHA vs ENLV Drawdown Comparison
The maximum drawdown for IPHA was -85.73%, occurring on Mar 20, 2026. This drawdown has not yet recovered.
The maximum drawdown for ENLV was -99.83%, occurring on Jun 12, 2026. This drawdown has not yet recovered.
The current IPHA drawdown is -78.54%. The current ENLV drawdown is -99.83%.
| Rank | IPHA | ENLV |
|---|---|---|
| #1 | -85.73% May 11, 2020 - Mar 20, 2026 | -99.83% Aug 27, 2014 - Jun 12, 2026 |
| #2 | -52.20% Feb 19, 2020 - May 11, 2020 | -17.86% Jul 31, 2014 - Aug 25, 2014 |
| #3 | -12.06% Nov 11, 2019 - Jan 2, 2020 | N/A |
| #4 | -10.16% Jan 23, 2020 - Feb 13, 2020 | N/A |
| #5 | -9.99% Jan 8, 2020 - Jan 23, 2020 | N/A |
| #6 | -8.86% Oct 21, 2019 - Nov 5, 2019 | N/A |
| #7 | -4.27% Feb 13, 2020 - Feb 18, 2020 | N/A |
| #8 | -3.22% Nov 7, 2019 - Nov 11, 2019 | N/A |
| #9 | -1.78% Jan 2, 2020 - Jan 6, 2020 | N/A |
Correlation
Correlation between IPHA and ENLV is 0.66 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks